RSV, Moderna and Marketing Authorization
Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.
A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...
What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...
Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.
Feb. 19, 2025 – A vaccine for pregnant women that protects babies from respiratory syncytial virus (RSV) appears safe, according to two new studies that give researchers hope for widespread ...
Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...
Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...
The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.
Expectant mums and elderly people who haven’t yet had their vaccination against the life-threatening RSV virus that is spreading in London ...
U.S. involvement in WHO flu meetings, the UK's approval of Moderna's RSV vaccine, efforts against a measles outbreak in Texas ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback